About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACAD - ACADIA Pharmaceutica...| Previous Close | $21.15 | Open | $21.37 |
| Volume | 430K | Market Cap | 3.41B |
| Yield | Last Dividend |
| The New England Journal of Medicine Publ... | 07/21/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced today that the New England Journal of Medicine published results from... | |
| Acadia Pharmaceuticals to Present New Sc... | 07/14/21 |
| SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that three scientific presentations in dementia-related psychos... | |
| Bear of the Day: Inovio Pharmaceuticals ... | 07/12/21 |
| Stocks Analysis by Zacks Investment Research covering: Pfizer Inc, ACADIA Pharmaceuticals Inc, Inovio Pharmaceuticals Inc, Moderna Inc. Read Zacks Inv... | |
| Hedge Funds Arent Crazy About ACADIA Pha... | 07/06/21 |
| No summary available. | |
| MONDAY DEADLINE ALERT: The Schall Law Fi... | 06/19/21 |
| MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. | |
| MONDAY DEADLINE ALERT: The Schall Law Fi... | 06/19/21 |
| LOS ANGELES(BUSINESS WIRE)$ACAD #ACADThe Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit a... | |
| DEADLINE TODAY: The Schall Law Firm Remi... | 06/18/21 |
| DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors | |
| DEADLINE TOMORROW: The Schall Law Firm R... | 06/17/21 |
| DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Invest | |
| ACAD SHAREHOLDER DEADLINE TOMORROW: Hage... | 06/17/21 |
| SAN FRANCISCO, June 17, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to s... | |
| The Law Offices of Frank R. Cruz Reminds... | 06/16/21 |
| The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD) | |
| Two Days Left to Actively Participate in... | 06/16/21 |
| Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against ACADIA Pharmaceutic | |
| FRIDAY DEADLINE NOTICE: The Schall Law F... | 06/16/21 |
| FRIDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages I | |
| FRIDAY DEADLINE ALERT: The Schall Law Fi... | 06/14/21 |
| FRIDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages In | |
| ACAD 6-DAY DEADLINE ALERT: Hagens Berman... | 06/12/21 |
| SAN FRANCISCO, June 12, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to s... | |
| DEADLINE ALERT: Bragar Eagel & Squire, P... | 06/11/21 |
| NEW YORK--(BUSINESS WIRE)-- #Action--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class ... | |
| ACAD BREAKING ALERT: ROSEN, A LONGSTANDI... | 06/11/21 |
| NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Acadia Pharmaceuticals Inc.... | |
| Should You Buy ACADIA Pharmaceuticals St... | 06/10/21 |
| Should You Buy ACADIA Pharmaceuticals Stock At $22? Forbes | |
| ACADIA Pharmaceuticals (ACAD) Initiated ... | 06/10/21 |
| ACADIA Pharmaceuticals (ACAD) received a Hold rating and a $29.00 price target from Berenberg Bank analyst Esther Hong today. The post ACADIA Pharmace... | |
| ACAD 11-DAY DEADLINE ALERT: Hagens Berma... | 06/07/21 |
| SAN FRANCISCO, June 07, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to s... | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 06/02/21 |
| NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that c... | |
| NUPLAZID?? (pimavanserin) Efficacy Data ... | 06/02/21 |
| Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced publication of open-label extension (OLE) data from patients experiencing hallucinations an... | |
| ROSEN, A LEADING LAW FIRM, Encourages Ac... | 05/30/21 |
| NEW YORK, May 30, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on b... | |
| Parkinson Disease Drug Market 2021, Prov... | 05/29/21 |
| The report on the Parkinson Disease Drug market provides a market analysis complete with a quantitative and qualitative assessment. The study looks in... | |
| ROSEN, SKILLED INVESTOR COUNSEL, Encoura... | 05/28/21 |
| NEW YORK, May 28, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a | |
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS,... | 05/28/21 |
| SAN FRANCISCO, May 28, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to su... | |
| SHAREHOLDER ACTION ALERT: The Schall Law... | 05/27/21 |
| SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent ACADIA Pharmaceuticals Inc. and E | |
| Bragar Eagel & Squire, P.C. Reminds Inve... | 05/26/21 |
| NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that cl... | |
| Acadia Pharmaceuticals to Present at Upc... | 05/25/21 |
| Jefferies 2021 Virtual Healthcare Conference Fireside Chat Presentation: Wednesday, June 2, 2021 at 1:30 p.m. Eastern Time. | |
| Acadia Pharmaceuticals, Inc. Investors: ... | 05/25/21 |
| Investors with losses are encouraged to contact the firm before June 18, 2021; click here to submit trade information | |
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS,... | 05/23/21 |
| SAN FRANCISCO, May 23, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Acadia Pharmaceuticals Inc. (NASDAQ: ACAD) investors with significant losses to su... | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Trading Systems | Trading Systems | 83.00 % | Follow |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Best Trading Ideas | Best Trading Ideas | 53.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
